Skip to main content

Table 6 Treatment efficacies at the last follow-up

From: A controlled clinical study on efficacy and safety of periocular triamcinolone acetonide injection for treating ocular myasthenia gravis

Treatment result

Study group(22cases)

Control group (38cases)

Statistical values

P

CSR

3 (13.6%)

5 (13.2%)

 

1.00

PR

8 (36.4%)

13 (34.2%)

0.81

1.00

MMS

6 (27.3%)

12 (31.6%)

0.73

0.78

Other cases

5 (22.7%)

8 (21.1%)

0.87

1.00

Relapsed

6 (27.3%)

15 (39.5%)

0.34

0.42

GMG

3(13.6%)

9(23.7%)

0.34

0.51

  1. Other cases: These include patients who do not respond to treatment, do not achieve MMS status, and undergo thymectomy.